Hyperglycemia decreases anti-cancer efficiency of Adriamycin via AMPK pathway.

Endocr Relat Cancer

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology & Toxicology and Biochemical Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Published: February 2020

The authors and journal apologise for an error in the above paper, which appeared in volume 25 part 11, pages 955–966. The error relates to the artwork of Fig. 5 on page 963, in which the blots given in panel E were mistakenly replicated in panel F.

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-18-0036DOI Listing

Publication Analysis

Top Keywords

hyperglycemia decreases
4
decreases anti-cancer
4
anti-cancer efficiency
4
efficiency adriamycin
4
adriamycin ampk
4
ampk pathway
4
pathway authors
4
authors journal
4
journal apologise
4
apologise error
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!